Literature DB >> 15822390

[Management of acute prostatitis, based on a series of 100 cases].

Charlotte Auzanneau1, Andréa Manunta, Sébastien Vincendeau, Jean-Jacques Patard, François Guillé, Bernard Lobel.   

Abstract

OBJECTIVES: To evaluate the current diagnostic and therapeutic management of acute prostatitis.
MATERIAL AND METHODS: The authors report a series of 100 consecutive patients with a diagnosis of acute prostatitis managed between January 1999 and December 2003. They analysed the clinical and laboratory data and imaging findings leading to the diagnosis of acute prostatitis and then the modalities of treatment and follow-up of these patients.
RESULTS: The median age was 56.5 years (range: 19-86 years). In 77% of cases, the initial septic syndrome was considered to be severe. Prostatic tenderness was detected on digital rectal examination in 68% of cases. In 76% of cases, the micro-organism responsible was Escherichia coli. 8% of patients had positive blood cultures. All patients presented laboratory signs of inflammatory syndrome, with elevated C Reactive Protein (CRP) in most cases. Renal and bladder ultrasound was performed in 49% of cases and CT was performed in 16% of cases. 92% of patients were treated with fluoroquinolones, as monotherapy in 34% of cases. The duration of prescription ranged from 2 weeks to 6 weeks. No aetiology was detected in 48% of cases, 8% were considered to be iatrogenic and 44% were associated with incomplete bladder emptying.
CONCLUSION: Acute prostatitis, rapidly treated by aggressive and adapted antibiotics has a rapidly favourable outcome. Elevation of CRP and the presence of leukocyturia on urine dipsticks are almost constant and, when they are normal, the diagnosis of acute prostatitis should be questioned. Imaging is not required in the absence of diagnostic doubt and any suspicion of progression to abscess. The duration of antibiotic therapy varies from prescriber to prescriber reflecting the various guidelines. Guidelines on this subject are contradictory and further effort is required to achieve homogenization and application of these guidelines.

Entities:  

Mesh:

Year:  2005        PMID: 15822390

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  5 in total

1.  Should blood cultures be performed for patients with acute prostatitis?

Authors:  Manuel Etienne; Martine Pestel-Caron; Claire Chapuzet; Ingrid Bourgeois; Pascal Chavanet; François Caron
Journal:  J Clin Microbiol       Date:  2010-03-17       Impact factor: 5.948

2.  Paucisymptomatic infectious prostatitis as a cause of fever without an apparent origin. A series of 19 patients.

Authors:  I Novo-Veleiro; M Hernández-Cabrera; F Cañas-Hernández; E Pisos-Álamo; A Francés-Urmeneta; M Delgado-Yagüe; L Alvela-Suárez; J-L Pérez-Arellano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-06       Impact factor: 3.267

3.  [Acute prostatitis associated with noncancerous prostate at the Lubumbashi University Clinics: epidemioclinical and therapeutic features].

Authors:  Manix Ilunga Banza; Trésor Kibangula Kasanga; Augustin Kibonge Mukakala; Yannick Tietie Ben N'dwala; Christelle Ngoie Ngoie; Vincent De Paul Kaoma Cabala; Néron Tapenge Shutsha; Lire Ipani Lire; Eric Wakunga Unen; Nathalie Dinganga Kapessa
Journal:  Pan Afr Med J       Date:  2020-12-01

4.  Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis.

Authors:  Manuel Etienne; Pascal Chavanet; Louis Sibert; Frédéric Michel; Hervé Levesque; Bernard Lorcerie; Jean Doucet; Pierre Pfitzenmeyer; François Caron
Journal:  BMC Infect Dis       Date:  2008-01-30       Impact factor: 3.090

5.  Value of Provoked or Spontaneous Flank Pain in Men with Febrile Urinary Tract Infections.

Authors:  Franck Bruyère; Joseph-Alain Ruimy; Louis Bernard; Raphael Elfassi; Olivier Boyer; Fabrice Amann; Paul Meria
Journal:  Antibiotics (Basel)       Date:  2014-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.